NPPA computed the Retail Price of Empagliflozin 12.5 mg + Metformin Hydrochloride IP 1000 mg (in extended release form) for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Cipla Ltd. (Marketer)

Feb 21, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific Compliance

The National Pharmaceutical Pricing Authority (NPPA) on February 19, 2025, issued the Computation of Retail Price of Empagliflozin 12.5 mg + Metformin Hydrochloride IP 1000 mg (in extended release form) for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Cipla Ltd. (Marketer)

The following has been stated namely: -

• The Retail Price has been computed based on the data from June, 2024

• The Retail Price has been computed for Each Film Coated Tablet Containing Empagliflozin 12.5 mg + Metformin Hydrochloride IP 1000 mg (in extended release form) for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Cipla Ltd. (Marketer)

• The Total MAT is 33,47,73,027


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT